DRRX - DURECT Net Sales Margin

Public company logo of durect.com (DRRX)

Data processing automation via software robots optimizes research at DURECT Corporation (DRRX), which correlates with the net margin. The value of -460.60 determines the current status of the parameter on the chart. Value growth is based on larsucosterol trials and patent protection. However, success depends on regulatory approval of the therapy and the availability of capital to launch mass production of the drugs.

DURECT Corp (DRRX) - Return on Sales by Net Profit from 07/04/2022 to 09/27/2025

durect.com (DRRX) - metric breakdowns and financial figures

- market value and analyst target forecast:
Basic company analysis:DURECT Corporation
Finished products of DURECT Corporation

When constructing a long-term portfolio, basic screening requires an assessment of how effectively revenue converts into profit. This indicator measures the share of net income relative to total sales, reflecting the business's operational efficiency. For DURECT Corporation (DRRX), this parameter is supported by exceptional pricing power due to the unique epigenetic impact of larsucosterol. Analyzing the net profit margin chart allows for the determination of trend sustainability and the risks of buying at the peak.